Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000019

Options or other derivatives

  • Chief Medical Officer acquired 170,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rodman David Malcom Chief Medical Officer 2025-02-13 Grant or award · Stock Option +170,000 170,000 D
Loading xslF345X05/wk-form4_1740441576.xml…